Not Signed In -
Tadalafil |
Cialis |
Tadalafil Systematic (IUPAC) name (6R-trans)-6-(1,3-benzodioxol-5-yl)- 2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino [1', 2':1,6] pyrido[3,4-b]indole-1,4-dione Identifiers CAS number 171596-29-5 ATC code G04BE08 PubChem 110635 DrugBank APRD00071 Chemical data Formula C22H19N3O4 Mol. weight 389.404 g/mol Pharmacokinetic data Bioavailability ? Protein binding 94% Metabolism ? Half life 17.5 hours Excretion ? Therapeutic considerations P ...
Wikipedia - [full article]
Tadalafil Clinical Trials
- PHIRST-1: Safety and Efficacy of Tadalafil in the Treatment of Pulmonary Arterial Hypertension
ClinicalTrials.gov Identifier: NCT00125918 - Active, not recruiting
Pulmonary Hypertension
- Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the Lungs
ClinicalTrials.gov Identifier: NCT00549302 - Active, not recruiting
Hypertension, Pulmonary
- Tadalafil in Subjects with Mild to Moderate Hypertension
ClinicalTrials.gov Identifier: NCT00157326 - Completed
Hypertension
- A Study of IC351 (tadalafil) for the treatment of diabetic patients with symptoms of dyspepsia (upset stomach) and gastroparesis (delayed gastric emptying).
ClinicalTrials.gov Identifier: NCT00050609 - Completed
Gastroparesis
- Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life
ClinicalTrials.gov Identifier: NCT00422734 - Recruiting
Impotence
- Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
ClinicalTrials.gov Identifier: NCT00384930 - Active, not recruiting
Benign Prostatic Hyperplasia
- Efficacy and Safety of Tadalafil in Hemodialysis Patients
ClinicalTrials.gov Identifier: NCT00334477 - Not yet recruiting
Erectile Dysfunction
- Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia in Asian Men
ClinicalTrials.gov Identifier: NCT00540124 - Recruiting
Benign Prostatic Hyperplasia
- Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
ClinicalTrials.gov Identifier: NCT00386009 - Recruiting
Benign Prostatic Hyperplasia
- A Study to Assess the Efficacy of Tadalafil to Treat Erectile Dysfunction After Radiotherapy of Prostate Cancer
ClinicalTrials.gov Identifier: NCT00122499 - Completed
Prostate Cancer; Erectile Dysfunction
- Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia
ClinicalTrials.gov Identifier: NCT00538564 - Recruiting
Sickle Cell Anemia; Priapism; Pulmonary Hypertension
- Effect of Tadalafil in Chronic Obstructive Lung Disease Patients Suffering From Secondary Pulmonary Hypertension
ClinicalTrials.gov Identifier: NCT00506701 - Not yet recruiting
Chronic Obstructive Lung Disease
- Determine If the Stress That Comes With Not Developing an Erection Affects Tadalafil Effects
ClinicalTrials.gov Identifier: NCT00547599 - Completed
Impotence
- Study For Which Treatment, Tadalafil or Sildenafil, is Preferred For Problems Getting or Maintaining an Erection
ClinicalTrials.gov Identifier: NCT00547092 - Completed
Impotence
- Studying the Preference of Tadalafil to Sildenafil in Men With Problems Getting an Erection Across Nations
ClinicalTrials.gov Identifier: NCT00547287 - Completed
Impotence
- Study to Determine a Preference Between Sildenafil or Tadalafil Treatment for Problems Getting an Erection
ClinicalTrials.gov Identifier: NCT00547352 - Completed
Impotence
- A Study of Semen Characteristics After 9 Months of Daily Tadalafil 20 mg
ClinicalTrials.gov Identifier: NCT00382135 - Completed
Erectile Dysfunction
- Study the Safety and Effectiveness of Tadalafil in Men With Diabetes Who Have Problems Getting and Keeping an Erection
ClinicalTrials.gov Identifier: NCT00547183 - Completed
Impotence
- To Determine Effect and Safety of Tadalafil Taken by Men of Different Races and With Different Diseases When Needed for Erections
ClinicalTrials.gov Identifier: NCT00547417 - Completed
Impotence
- Determine Safety and Effectiveness of Tadalafil in Asian Men When Taken as Needed for Getting and Keeping an Erection
ClinicalTrials.gov Identifier: NCT00547573 - Completed
Impotence
- To Determine How Different Doses of Tadalafil Work on Getting and Keeping an Erection 26 or 36 Hours After Taking
ClinicalTrials.gov Identifier: NCT00547508 - Completed
Impotence
- Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer?
ClinicalTrials.gov Identifier: NCT00215631 - Terminated
Prostate Cancer; Erectile Dysfunction
- Study the Safety and Effectiveness of Tadalafil in Men With Problems Getting or Maintaining an Erection When Taken Prior to Desiring an Erection
ClinicalTrials.gov Identifier: NCT00547495 - Completed
Impotence
- Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems
ClinicalTrials.gov Identifier: NCT00547625 - Completed
Prostatic Hyperplasia; Prostate
- A Study to Evaluate the Efficacy and Safety of 2.5mg and 5mg Tadalafil Given Once a Day to Men With Erectile Dysfunction
ClinicalTrials.gov Identifier: NCT00381732 - Completed
Erectile Dysfunction
- Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile Dysfunction
ClinicalTrials.gov Identifier: NCT00422578 - Completed
Impotence; Erectile Dysfunction
- Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury
ClinicalTrials.gov Identifier: NCT00421083 - Completed
Erectile Dysfunction; Spinal Cord Injuries
Resources
- Cialis (Drug Digest)
- Cialis Consumer Information (U.S. Food and Drug Administration)
email this page
print this page
bookmark this page
feedback on this page
